Salt of aliskiren with sulfuric acid

Details for Australian Patent Application No. 2007228996 (hide)

Owner Novartis AG

Inventors Stowasser, Frank; Allmendinger, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2007228996

PCT Pub. Number WO2007/107317

Priority 0605688.1 21.03.06 GB

Filing date 19 March 2007

Wipo publication date 27 September 2007

Acceptance publication date 4 August 2011

International Classifications

C07C 237/22 (2006.01) Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

11 September 2008 PCT application entered the National Phase

  PCT publication WO2007/107317 Priority application(s): WO2007/107317

4 August 2011 Application Accepted

  Published as AU-B-2007228996

1 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007228997-Pharmaceutical combination composition comprising at least one PKC inhibitor and at least one JAK3 kinase inhibitor for treating autoimmune disorders

2007228984-Treatment of triple receptor negative breast cancer